Pancreatic Neoplasm
Information
- Disease name
- Pancreatic Neoplasm
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03310632 | Active, not recruiting | Phase 1/Phase 2 | Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer | December 1, 2017 | March 31, 2024 |
| NCT00034281 | Completed | Phase 1 | Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 | June 2002 | September 2003 |
| NCT00222898 | Completed | Cancer Detection in Pancreatic Cysts | June 2004 | ||
| NCT00267020 | Completed | Phase 2 | Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer | December 2005 | May 2008 |
| NCT00436423 | Completed | Phase 2 | A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer | March 2006 | |
| NCT00438906 | Completed | Cancer of the Pancreas Screening Study (CAPS 3) | December 2006 | December 2009 | |
| NCT00005926 | Completed | Phase 2 | Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas | June 2000 | December 2000 |
| NCT00657995 | Completed | N/A | Tight Glycemic Control by Artificial Pancreas | April 2007 | December 2007 |
| NCT00666926 | Completed | Phase 1 | Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms | December 2005 | April 2009 |
| NCT00711191 | Completed | Phase 1 | A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas | June 2008 | January 2011 |
| NCT01278381 | Completed | Prognostic Score To Predict Major Complications After Pancreaticoduodenectomy | January 2002 | October 2010 | |
| NCT01354795 | Completed | N/A | Prospective Study Comparing Methods of Obtainment of Specimen After EUS-FNA in Patients With Peri-pancreatic Mass | September 2010 | March 2011 |
| NCT01394159 | Completed | N/A | 22G FNA Needle vs. 22G ProCore Needle | July 2011 | December 2011 |
| NCT01420874 | Completed | Phase 1 | Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer) | August 17, 2011 | October 19, 2020 |
| NCT01677312 | Completed | N/A | Trial Comparing 19 and 25-gauge EUS-FNA Needles | August 2012 | January 2013 |
| NCT01996540 | Completed | N/A | The Role of Early Systematic Best Palliative Care Versus on Request Palliative Care Consultation During Standard Oncologic Treatment for Patients With Advanced Gastric or Pancreatic Cancers: a Randomized, Controlled, Multicenter Trial. | August 2012 | November 2018 |
| NCT02092519 | Completed | Phase 4 | RCT: Difference in Diagnostic Yield Between EUSFNA Needles With and Without a Side Port in Pancreatic Masses | April 2013 | February 2015 |
| NCT02181140 | Completed | N/A | Core Biopsy Endo Sonography Study Evaluation of the Significance of the Pro-core® Needle | August 2011 | October 2014 |
| NCT02791503 | Completed | N/A | CROSSFIRE Trial: Comparing the Efficacy of Irreversible Electroporation With Radiotherapy | May 30, 2016 | September 2022 |
| NCT02900950 | Completed | N/A | Multicolour Versus Monocolour Specimens Inking After Pancreaticoduodenectomy for Periampullary Cancer | June 2012 | January 2016 |
| NCT02910960 | Completed | N/A | Comparison of Two Fine Needle Biopsy Needles for Solid Pancreatic Masses | December 2016 | October 2018 |
| NCT02911974 | Completed | N/A | Comparing Biopsy Needles for Endoscopic Ultrasound Guided Samples for Pancreatic Masses | August 2016 | August 2018 |
| NCT03033225 | Completed | Phase 2 | Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study | December 6, 2016 | September 20, 2023 |
| NCT03111368 | Completed | N/A | EUS-FNA of Solid Pancreatic Mass: Comparison Between Negative Pressure and Slow-pull Technique | April 27, 2015 | June 23, 2016 |
| NCT03322592 | Completed | N/A | EUS-FNB With ROSE Vs. EUS-FNB Without ROSE | March 29, 2018 | July 30, 2020 |
| NCT03616431 | Completed | Pancreatic Cancer Dietary Assessment Study | July 3, 2018 | May 31, 2021 | |
| NCT03622229 | Completed | N/A | EUS-FNB for Solid Pancreatic Lesions: Side-fenestrated Vs Fork-tip Needle | November 1, 2018 | August 30, 2020 |
| NCT03807999 | Completed | Phase 2 | Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas Cancer | February 19, 2015 | November 1, 2018 |
| NCT05745415 | Completed | Cancer Stem Cell Specific Aptamer's Ability to Detect Blood Circulating Cancer Stem Cells and Its Role as a Predictor of Prognosis in Pancreatic Cancer | March 29, 2018 | March 29, 2021 | |
| NCT04693754 | Enrolling by invitation | Endoscopic Ultrasound Radiofrequency Ablation, Database Repository | July 1, 2020 | December 31, 2030 | |
| NCT03541486 | Not yet recruiting | Phase 2 | A Clinical Trial Evaluating the Effect of Pharmacological Ascorbate on Radiation Therapy for Pancreatic Cancer Patients | December 31, 2025 | December 31, 2030 |
| NCT05786716 | Recruiting | Phase 2/Phase 3 | DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Teenage/Young Adult and Paediatric Patients With Cancers With HER2 Amplification or Activating Mutations | March 7, 2023 | October 2029 |
| NCT05961982 | Recruiting | N/A | Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study | April 24, 2023 | December 31, 2025 |
| NCT06051695 | Recruiting | Phase 1/Phase 2 | A Study to Evaluate the Safety and Efficacy of A2B694, a Logic-gated CAR T, in Subjects With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression | April 3, 2024 | June 2029 |
| NCT06122896 | Recruiting | Early Phase 1 | Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals | November 21, 2023 | October 31, 2041 |
| NCT06400472 | Recruiting | Phase 1 | A Study of LY4170156 in Participants With Selected Advanced Solid Tumors | May 6, 2024 | April 2027 |
| NCT04493632 | Recruiting | OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. | April 12, 2022 | October 1, 2027 | |
| NCT05083247 | Recruiting | Phase 2 | Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma | March 24, 2023 | December 31, 2030 |
| NCT05259384 | Recruiting | N/A | Robotic Versus Laparoscopic Surgery for Patients With Pancreatic Cystic Neoplasms | April 17, 2021 | October 31, 2024 |
| NCT05428358 | Recruiting | N/A | Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery | August 30, 2022 | September 1, 2027 |
| NCT05494866 | Recruiting | Phase 1 | A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients With Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma | December 7, 2022 | February 28, 2025 |
| NCT05687123 | Recruiting | Phase 1 | Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors | July 4, 2024 | June 14, 2025 |
| NCT06411795 | Recruiting | Phase 2 | Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy | November 10, 2023 | January 1, 2026 |
| NCT00249301 | Terminated | Phase 1 | A Study of MLN8054 in Patients With Advanced Solid Tumors | October 2005 | |
| NCT02602067 | Terminated | Phase 1 | 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients | November 2015 | April 30, 2017 |
| NCT00574275 | Terminated | Phase 3 | Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer | December 2007 | November 2010 |
| NCT00958841 | Terminated | Phase 2 | Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin | September 2009 | June 2015 |
| NCT02456051 | Terminated | Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients | April 2015 | November 2017 | |
| NCT00602745 | Terminated | Phase 3 | S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based Regimen | February 2008 | March 2010 |
| NCT04164017 | Unknown status | N/A | Impact of Suction in the EUS-guided Fine Needle Biopsy of Solid Pancreatic Lesions | June 1, 2019 | April 1, 2020 |
| NCT04662346 | Unknown status | N/A | Evaluation of Difficulty Score for Robotic Pancreatoduodenectomy | December 1, 2020 | February 28, 2021 |
| NCT04623749 | Unknown status | N/A | Percutaneous Versus EUS FNAC in Pancreatic Masses | December 2021 | March 2023 |
| NCT03269955 | Unknown status | Phase 4 | The Effect of Application of TachoSil® in Pancreatoduodenectomy | February 27, 2017 | May 2018 |
| NCT04718701 | Unknown status | Phase 2 | Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic Cancer | April 1, 2021 | February 1, 2023 |
| NCT04843956 | Unknown status | N/A | Comparison of EUS-FNB Biopsy Techniques of Solid Pancreatic Lesions | January 8, 2020 | April 30, 2021 |
| NCT05222204 | Unknown status | Phase 2 | DDP ip Combined With AG in PDAC With Peritoneal Metastasis | July 2, 2021 | July 2, 2023 |
| NCT02436564 | Unknown status | In Vitro Models of Liver and Pancreatic Cancer | July 2015 |